According to data shared by the CDC last year, around 34% of patients who contracted COVID between 2020 and 2023 reported losing their sense of smell.
COVID-19 survivors face significantly higher risks of developing neuropsychiatric conditions, but vaccination reduces these risks over time.
COVID-19 vaccines were found to cut risk of heart failure by up to 55% and blood clots by up to 78% following COVID infection, according to a new study.
A team from Ireland identified disruptions to the integrity of the blood vessels in the brains of patients experiencing brain fog due to the disease.
Researchers at Oakland, Calif.-based Kaiser Permanente identified 17 conditions most frequently associated with long COVID-19 in a study published Oct. 12 in Nature Medicine. The study is among the first to account for preexisting conditions when defining such symptoms.
The condition - which is mild for most but can cause a recurrent heart palpitation in rare cases - was most common after the second dose, researchers at Kaiser Permanente found.
Exposure to air pollution increases the risk of COVID-19 hospitalization, according to a new study.
Post-COVID, or long COVID, can develop in approximately one in eight people with COVID-19, according to data published in The Lancet.
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.
Top scientists from leading academic centers are banding together to answer a key question about the root cause of long COVID - whether fragments of the coronavirus persist in the tissues of some individuals.
People who said they were stressed, anxious, lonely, depressed or worried about Covid before getting infected had a higher risk of long Covid symptoms.
NEW DELHI (AP) — India and China have cleared a new approach in COVID-19 vaccination — two needle-free options, one a squirt in the nose and the other inhaled through the mouth. Regulators in India authorized Bharat Biotech's nasal version on Tuesday as an option for people who haven't yet been vaccinated.